Appleton Partners Inc. MA Purchases 104 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Appleton Partners Inc. MA boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 0.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,803 shares of the financial services provider’s stock after buying an additional 104 shares during the quarter. Appleton Partners Inc. MA owned approximately 0.16% of iShares Biotechnology ETF worth $10,022,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in IBB. Huntington National Bank raised its position in shares of iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after acquiring an additional 160 shares during the last quarter. National Bank of Canada FI increased its position in iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares during the period. Avior Wealth Management LLC raised its holdings in iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after purchasing an additional 2,629 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Finally, Main Management ETF Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 2.5% in the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after purchasing an additional 14,535 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.1 %

IBB opened at $137.67 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The company has a fifty day moving average of $136.22 and a 200-day moving average of $141.41.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.